Campylobacter infection and related illness is associated with a substantial economic burden in Germany, according to a study.
Researchers analyzed the use of health care and direct and indirect costs of Campylobacter and care-intensive long-lasting health issues of patients from health insurance data with 26 million members in Germany.
Claims
Continue Reading Researchers estimate Campylobacter costs in Germany